{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:21:37Z","timestamp":1792524097962,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00246-019-02151-x","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T04:59:54Z","timestamp":1566449994000},"page":"1419-1430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["Long QT Syndrome: Genetics and Future Perspective"],"prefix":"10.1007","volume":"40","author":[{"given":"Eimear","family":"Wallace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanbing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3824-636X","authenticated-orcid":false,"given":"Terence","family":"Prendiville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"issue":"18","key":"2151_CR1","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","volume":"120","author":"PJ Schwartz","year":"2009","unstructured":"Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G, Gabbarini F, Goulene K, Insolia R, Mannarino S, Mosca F, Nespoli L, Rimini A, Rosati E, Salice P, Spazzolini C (2009) Prevalence of the congenital long-QT syndrome. Circulation 120(18):1761\u20131767. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.863209","journal-title":"Circulation"},{"issue":"3","key":"2151_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jacc.2013.04.044","volume":"62","author":"PJ Schwartz","year":"2013","unstructured":"Schwartz PJ, Ackerman MJ, George AL Jr, Wilde AAM (2013) Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol 62(3):169\u2013180. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2013.04.044","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2151_CR3","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.hrthm.2010.09.017","volume":"7","author":"JN Weiss","year":"2010","unstructured":"Weiss JN, Garfinkel A, Karagueuzian HS, Chen PS, Qu Z (2010) Early afterdepolarizations and cardiac arrhythmias. Heart Rhythm 7(12):1891\u20131899. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2010.09.017","journal-title":"Heart Rhythm"},{"issue":"2","key":"2151_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0002-8703(85)90626-X","volume":"109","author":"PJ Schwartz","year":"1985","unstructured":"Schwartz PJ (1985) Idiopathic long QT syndrome: progress and questions. Am Heart J 109(2):399\u2013411","journal-title":"Am Heart J"},{"issue":"4","key":"2151_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jacc.2017.05.046","volume":"70","author":"RK Rohatgi","year":"2017","unstructured":"Rohatgi RK, Sugrue A, Bos JM, Cannon BC, Asirvatham SJ, Moir C, Owen HJ, Bos KM, Kruisselbrink T, Ackerman MJ (2017) Contemporary outcomes in patients with long QT syndrome. J Am Coll Cardiol 70(4):453\u2013462. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2017.05.046","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2151_CR6","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1253\/circj.CJ-14-0905","volume":"78","author":"Y Mizusawa","year":"2014","unstructured":"Mizusawa Y, Horie M, Wilde AA (2014) Genetic and clinical advances in congenital long QT syndrome. Circ J 78(12):2827\u20132833","journal-title":"Circ J"},{"issue":"4","key":"2151_CR7","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/CIRCEP.111.962019","volume":"5","author":"PJ Schwartz","year":"2012","unstructured":"Schwartz PJ, Crotti L, Insolia R (2012) Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol 5(4):868\u2013877. \n                    https:\/\/doi.org\/10.1161\/CIRCEP.111.962019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"2151_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ccep.2016.01.004","volume":"8","author":"L Chen","year":"2016","unstructured":"Chen L, Sampson KJ, Kass RS (2016) Cardiac delayed rectifier potassium channels in health and disease. Cardiac Electrophysiol Clin 8(2):307\u2013322. \n                    https:\/\/doi.org\/10.1016\/j.ccep.2016.01.004","journal-title":"Cardiac Electrophysiol Clin"},{"issue":"25","key":"2151_CR9","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1161\/CIRCULATIONAHA.110.981381","volume":"123","author":"S Modi","year":"2011","unstructured":"Modi S, Krahn AD (2011) Sudden cardiac arrest without overt heart disease. Circulation 123(25):2994\u20133008. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.981381","journal-title":"Circulation"},{"issue":"19","key":"2151_CR10","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMoa022147","volume":"348","author":"SG Priori","year":"2003","unstructured":"Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D (2003) Risk stratification in the long-QT syndrome. N Engl J Med 348(19):1866\u20131874. \n                    https:\/\/doi.org\/10.1056\/NEJMoa022147","journal-title":"N Engl J Med"},{"issue":"11","key":"2151_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1001\/jama.292.11.1341","volume":"292","author":"SG Priori","year":"2004","unstructured":"Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E, Moncalvo C, Tulipani C, Veia A, Bottelli G, Nastoli J (2004) Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 292(11):1341\u20131344. \n                    https:\/\/doi.org\/10.1001\/jama.292.11.1341","journal-title":"JAMA"},{"issue":"3","key":"2151_CR12","doi-asserted-by":"publisher","first-page":"aar2631","DOI":"10.1126\/sciadv.aar2631","volume":"4","author":"H Huang","year":"2018","unstructured":"Huang H, Kuenze G, Smith JA, Taylor KC, Duran AM, Hadziselimovic A, Meiler J, Vanoye CG, George AL Jr, Sanders CR (2018) Mechanisms of KCNQ1 channel dysfunction in long QT syndrome involving voltage sensor domain mutations. Sci Adv 4(3):aar2631. \n                    https:\/\/doi.org\/10.1126\/sciadv.aar2631","journal-title":"Sci Adv"},{"issue":"16","key":"2151_CR13","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1161\/CIRCULATIONAHA.111.048041","volume":"125","author":"A Barsheshet","year":"2012","unstructured":"Barsheshet A, Goldenberg I, O-Uchi J, Moss AJ, Jons C, Shimizu W, Wilde AA, McNitt S, Peterson DR, Zareba W, Robinson JL, Ackerman MJ, Cypress M, Gray DA, Hofman N, Kanters JK, Kaufman ES, Platonov PG, Qi M, Towbin JA, Vincent GM, Lopes CM, (2012) Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to beta-blocker therapy in type 1 long-QT syndrome. Circulation 125(16):1988\u20131996. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.048041","journal-title":"Circulation"},{"issue":"3","key":"2151_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/archdischild-2014-306864","volume":"100","author":"KE Waddell-Smith","year":"2015","unstructured":"Waddell-Smith KE, Earle N, Skinner JR (2015) Must every child with long QT syndrome take a beta blocker? Arch Dis Child 100(3):279\u2013282. \n                    https:\/\/doi.org\/10.1136\/archdischild-2014-306864","journal-title":"Arch Dis Child"},{"issue":"3","key":"2151_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/cvr\/cvu060","volume":"102","author":"A Mehta","year":"2014","unstructured":"Mehta A, Sequiera GL, Ramachandra CJ, Sudibyo Y, Chung Y, Sheng J, Wong KY, Tan TH, Wong P, Liew R, Shim W (2014) Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes. Cardiovasc Res 102(3):497\u2013506. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvu060","journal-title":"Cardiovasc Res"},{"issue":"10","key":"2151_CR16","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jacc.2006.09.054","volume":"49","author":"R Seth","year":"2007","unstructured":"Seth R, Moss AJ, McNitt S, Zareba W, Andrews ML, Qi M, Robinson JL, Goldenberg I, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L (2007) Long QT syndrome and pregnancy. J Am Coll Cardiol 49(10):1092\u20131098. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2006.09.054","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2151_CR17","doi-asserted-by":"publisher","first-page":"e83005","DOI":"10.1371\/journal.pone.0083005","volume":"8","author":"A Fatima","year":"2013","unstructured":"Fatima A, Kaifeng S, Dittmann S, Xu G, Gupta MK, Linke M, Zechner U, Nguemo F, Milting H, Farr M, Hescheler J, Saric T (2013) The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients. PLoS ONE 8(12):e83005. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0083005","journal-title":"PLoS ONE"},{"issue":"6","key":"2151_CR18","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1016\/j.ijcard.2013.08.015","volume":"168","author":"D Ma","year":"2013","unstructured":"Ma D, Wei H, Zhao Y, Lu J, Li G, Sahib NB, Tan TH, Wong KY, Shim W, Wong P, Cook SA, Liew R (2013) Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. Int J Cardiol 168(6):5277\u20135286. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2013.08.015","journal-title":"Int J Cardiol"},{"issue":"25","key":"2151_CR19","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1161\/CIRCULATIONAHA.111.066092","volume":"125","author":"RP Davis","year":"2012","unstructured":"Davis RP, Casini S, van den Berg CW, Hoekstra M, Remme CA, Dambrot C, Salvatori D, Oostwaard DW, Wilde AA, Bezzina CR, Verkerk AO, Freund C, Mummery CL (2012) Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation 125(25):3079\u20133091. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.066092","journal-title":"Circulation"},{"issue":"1","key":"2151_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.yjmcc.2009.08.025","volume":"48","author":"H Abriel","year":"2010","unstructured":"Abriel H (2010) Cardiac sodium channel Na(v)1.5 and interacting proteins: physiology and pathophysiology. J Mol Cell Cardiol 48(1):2\u201311. \n                    https:\/\/doi.org\/10.1016\/j.yjmcc.2009.08.025","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"2151_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00395-016-0530-0","volume":"111","author":"D Malan","year":"2016","unstructured":"Malan D, Zhang M, Stallmeyer B, Muller J, Fleischmann BK, Schulze-Bahr E, Sasse P, Greber B (2016) Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction. Basic Res Cardiol 111(2):14. \n                    https:\/\/doi.org\/10.1007\/s00395-016-0530-0","journal-title":"Basic Res Cardiol"},{"issue":"50","key":"2151_CR22","doi-asserted-by":"publisher","first-page":"E5383","DOI":"10.1073\/pnas.1419553111","volume":"111","author":"M Zhang","year":"2014","unstructured":"Zhang M, D'Aniello C, Verkerk AO, Wrobel E, Frank S, Ward-van Oostwaard D, Piccini I, Freund C, Rao J, Seebohm G, Atsma DE, Schulze-Bahr E, Mummery CL, Greber B, Bellin M (2014) Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue. Proc Natl Acad Sci USA 111(50):E5383\u20135392. \n                    https:\/\/doi.org\/10.1073\/pnas.1419553111","journal-title":"Proc Natl Acad Sci USA"},{"key":"2151_CR23","volume-title":"GeneReviews\u00ae","author":"A Veerapandiyan","year":"1993","unstructured":"Veerapandiyan A, Statland JM, Tawil R (1993) Andersen-Tawil syndrome. In: Adam MP, Ardinger HH, Pagon RA et al. (eds) GeneReviews\u00ae. University of Washington, Seattle"},{"issue":"15","key":"2151_CR24","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.jacc.2018.01.078","volume":"71","author":"A Mazzanti","year":"2018","unstructured":"Mazzanti A, Maragna R, Vacanti G, Monteforte N, Bloise R, Marino M, Braghieri L, Gambelli P, Memmi M, Pagan E, Morini M, Malovini A, Ortiz M, Sacilotto L, Bellazzi R, Monserrat L, Napolitano C, Bagnardi V, Priori SG (2018) Interplay between genetic substrate, QTc duration, and arrhythmia risk in patients with long QT syndrome. J Am Coll Cardiol 71(15):1663\u20131671. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2018.01.078","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"2151_CR25","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1161\/CIRCULATIONAHA.106.661082","volume":"115","author":"NW Taggart","year":"2007","unstructured":"Taggart NW, Haglund CM, Tester DJ, Ackerman MJ (2007) Diagnostic miscues in congenital long-QT syndrome. Circulation 115(20):2613\u20132620. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.661082","journal-title":"Circulation"},{"issue":"20","key":"2151_CR26","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1161\/CIRCULATIONAHA.111.028258","volume":"124","author":"RW Sy","year":"2011","unstructured":"Sy RW, van der Werf C, Chattha IS, Chockalingam P, Adler A, Healey JS, Perrin M, Gollob MH, Skanes AC, Yee R, Gula LJ, Leong-Sit P, Viskin S, Klein GJ, Wilde AA, Krahn AD (2011) Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation 124(20):2187\u20132194. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.028258","journal-title":"Circulation"},{"issue":"1","key":"2151_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.hrthm.2015.08.037","volume":"13","author":"A Page","year":"2016","unstructured":"Page A, Aktas MK, Soyata T, Zareba W, Couderc JP (2016) \"QT clock\" to improve detection of QT prolongation in long QT syndrome patients. Heart Rhythm 13(1):190\u2013198. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2015.08.037","journal-title":"Heart Rhythm"},{"issue":"13","key":"2151_CR28","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jacc.2014.05.068","volume":"64","author":"A Abu-Zeitone","year":"2014","unstructured":"Abu-Zeitone A, Peterson DR, Polonsky B, McNitt S, Moss AJ (2014) Efficacy of different beta-blockers in the treatment of long QT syndrome. J Am Coll Cardiol 64(13):1352\u20131358. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2014.05.068","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2151_CR29","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.jacc.2003.07.006","volume":"42","author":"SP Etheridge","year":"2003","unstructured":"Etheridge SP, Compton SJ, Tristani-Firouzi M, Mason JW (2003) A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations. J Am Coll Cardiol 42(10):1777\u20131782","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"2151_CR30","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/eurheartj\/ehx394","volume":"39","author":"A Mehta","year":"2018","unstructured":"Mehta A, Ramachandra CJA, Singh P, Chitre A, Lua CH, Mura M, Crotti L, Wong P, Schwartz PJ, Gnecchi M, Shim W (2018) Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model. Eur Heart J 39(16):1446\u20131455. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehx394","journal-title":"Eur Heart J"},{"issue":"1","key":"2151_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","volume":"103","author":"PJ Schwartz","year":"2001","unstructured":"Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R (2001) Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103(1):89\u201395","journal-title":"Circulation"},{"issue":"6923","key":"2151_CR32","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nature01335","volume":"421","author":"PJ Mohler","year":"2003","unstructured":"Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, duBell WH, Song LS, Haurogne K, Kyndt F, Ali ME, Rogers TB, Lederer WJ, Escande D, Le Marec H, Bennett V (2003) Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421(6923):634\u2013639. \n                    https:\/\/doi.org\/10.1038\/nature01335","journal-title":"Nature"},{"issue":"3","key":"2151_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cardiores.2005.03.020","volume":"67","author":"W Shimizu","year":"2005","unstructured":"Shimizu W (2005) The long QT syndrome: therapeutic implications of a genetic diagnosis. Cardiovasc Res 67(3):347\u2013356. \n                    https:\/\/doi.org\/10.1016\/j.cardiores.2005.03.020","journal-title":"Cardiovasc Res"},{"issue":"3","key":"2151_CR34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.hrthm.2014.12.009","volume":"12","author":"K Miyamoto","year":"2015","unstructured":"Miyamoto K, Aiba T, Kimura H, Hayashi H, Ohno S, Yasuoka C, Tanioka Y, Tsuchiya T, Yoshida Y, Tsuboi I, Nakajima I, Ishibashi K, Okamura H, Noda T, Ishihara M, Anzai T, Yasuda S, Miyamoto Y, Kamakura S, Kusano K, Ogawa H, Horie M, Shimizu W (2015) Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations. Heart Rhythm 12(3):596\u2013603. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2014.12.009","journal-title":"Heart Rhythm"},{"issue":"2","key":"2151_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.nurt.2007.01.005","volume":"4","author":"V Sansone","year":"2007","unstructured":"Sansone V, Tawil R (2007) Management and treatment of Andersen-Tawil syndrome (ATS). Neurotherapeutics 4(2):233\u2013237. \n                    https:\/\/doi.org\/10.1016\/j.nurt.2007.01.005","journal-title":"Neurotherapeutics"},{"issue":"4","key":"2151_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jacep.2017.08.007","volume":"4","author":"KA Dufendach","year":"2018","unstructured":"Dufendach KA, Timothy K, Ackerman MJ, Blevins B, Pflaumer A, Etheridge S, Perry J, Blom NA, Temple J, Chowdhury D, Skinner JR, Johnsrude C, Bratincsak A, Bos JM, Shah M (2018) Clinical outcomes and modes of death in timothy syndrome: a multicenter international study of a rare disorder. JACC Clin Electrophysiol 4(4):459\u2013466. \n                    https:\/\/doi.org\/10.1016\/j.jacep.2017.08.007","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"2151_CR37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.pharmthera.2008.02.001","volume":"118","author":"C Patel","year":"2008","unstructured":"Patel C, Antzelevitch C (2008) Pharmacological approach to the treatment of long and short QT syndromes. Pharmacol Ther 118(1):138\u2013151. \n                    https:\/\/doi.org\/10.1016\/j.pharmthera.2008.02.001","journal-title":"Pharmacol Ther"},{"issue":"15","key":"2151_CR38","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1161\/01.CIR.0000125523.14403.1E","volume":"109","author":"PJ Schwartz","year":"2004","unstructured":"Schwartz PJ, Priori SG, Cerrone M, Spazzolini C, Odero A, Napolitano C, Bloise R, De Ferrari GM, Klersy C, Moss AJ, Zareba W, Robinson JL, Hall WJ, Brink PA, Toivonen L, Epstein AE, Li C, Hu D (2004) Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation 109(15):1826\u20131833. \n                    https:\/\/doi.org\/10.1161\/01.CIR.0000125523.14403.1E","journal-title":"Circulation"},{"issue":"21","key":"2151_CR39","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1016\/j.jacc.2015.09.042","volume":"66","author":"MJ Ackerman","year":"2015","unstructured":"Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac channelopathies: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 66(21):2424\u20132428. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2015.09.042","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2151_CR40","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1253\/circj.CJ-14-0182","volume":"78","author":"K Sallam","year":"2014","unstructured":"Sallam K, Kodo K, Wu JC (2014) Modeling inherited cardiac disorders. Circ J 78(4):784\u2013794","journal-title":"Circ J"},{"issue":"4","key":"2151_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tcm.2012.09.006","volume":"23","author":"S Friedrichs","year":"2013","unstructured":"Friedrichs S, Malan D, Sasse P (2013) Modeling long QT syndromes using induced pluripotent stem cells: current progress and future challenges. Trends Cardiovasc Med 23(4):91\u201398. \n                    https:\/\/doi.org\/10.1016\/j.tcm.2012.09.006","journal-title":"Trends Cardiovasc Med"},{"issue":"3","key":"2151_CR42","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.227512","volume":"111","author":"CL Mummery","year":"2012","unstructured":"Mummery CL, Zhang J, Ng ES, Elliott DA, Elefanty AG, Kamp TJ (2012) Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res 111(3):344\u2013358. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.227512","journal-title":"Circ Res"},{"issue":"5","key":"2151_CR43","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1161\/CIRCULATIONAHA.108.778795","volume":"118","author":"C Mauritz","year":"2008","unstructured":"Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, Maier LS, Nguemo F, Menke S, Haustein M, Hescheler J, Hasenfuss G, Martin U (2008) Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118(5):507\u2013517. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.778795","journal-title":"Circulation"},{"issue":"5","key":"2151_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000074542","volume":"13","author":"M Halbach","year":"2003","unstructured":"Halbach M, Egert U, Hescheler J, Banach K (2003) Estimation of action potential changes from field potential recordings in multicellular mouse cardiac myocyte cultures. Cell Physiol Biochem 13(5):271\u2013284. \n                    https:\/\/doi.org\/10.1159\/000074542","journal-title":"Cell Physiol Biochem"},{"issue":"15","key":"2151_CR45","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa0908679","volume":"363","author":"A Moretti","year":"2010","unstructured":"Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flugel L, Dorn T, Goedel A, Hohnke C, Hofmann F, Seyfarth M, Sinnecker D, Schomig A, Laugwitz KL (2010) Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363(15):1397\u20131409. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0908679","journal-title":"N Engl J Med"},{"key":"2151_CR46","doi-asserted-by":"publisher","first-page":"496501","DOI":"10.1155\/2013\/496501","volume":"2013","author":"M Muller","year":"2013","unstructured":"Muller M, Seufferlein T, Illing A, Homann J (2013) Modelling human channelopathies using induced pluripotent stem cells: a comprehensive review. Stem Cells Int 2013:496501. \n                    https:\/\/doi.org\/10.1155\/2013\/496501","journal-title":"Stem Cells Int"},{"key":"2151_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/978-1-4939-7362-0_2","volume":"1684","author":"H Wei","year":"2018","unstructured":"Wei H, Wu J, Liu Z (2018) Studying KCNQ1 mutation and drug response in type 1 long QT syndrome using patient-specific induced pluripotent stem cell-derived cardiomyocytes. Methods Mol Biol 1684:7\u201328. \n                    https:\/\/doi.org\/10.1007\/978-1-4939-7362-0_2","journal-title":"Methods Mol Biol"},{"key":"2151_CR48","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.scr.2018.04.002","volume":"29","author":"M Mura","year":"2018","unstructured":"Mura M, Lee YK, Ginevrino M, Zappatore R, Pisano F, Boni M, Dagradi F, Crotti L, Valente EM, Schwartz PJ, Tse HF, Gnecchi M (2018) Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene. Stem Cell Res 29:157\u2013161. \n                    https:\/\/doi.org\/10.1016\/j.scr.2018.04.002","journal-title":"Stem Cell Res"},{"key":"2151_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13287-015-0027-z","volume":"6","author":"D Ma","year":"2015","unstructured":"Ma D, Wei H, Lu J, Huang D, Liu Z, Loh LJ, Islam O, Liew R, Shim W, Cook SA (2015) Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther 6:39. \n                    https:\/\/doi.org\/10.1186\/s13287-015-0027-z","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"2151_CR50","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.hrthm.2018.05.028","volume":"15","author":"Y Wuriyanghai","year":"2018","unstructured":"Wuriyanghai Y, Makiyama T, Sasaki K, Kamakura T, Yamamoto Y, Hayano M, Harita T, Nishiuchi S, Chen J, Kohjitani H, Hirose S, Yokoi F, Gao J, Chonabayashi K, Watanabe K, Ohno S, Yoshida Y, Kimura T, Horie M (2018) Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation. Heart Rhythm 15(10):1566\u20131574. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2018.05.028","journal-title":"Heart Rhythm"},{"key":"2151_CR51","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.scr.2018.04.003","volume":"29","author":"M Mura","year":"2018","unstructured":"Mura M, Ginevrino M, Zappatore R, Pisano F, Boni M, Castelletti S, Crotti L, Valente EM, Schwartz PJ, Gnecchi M (2018) Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1. Stem Cell Res 29:170\u2013173. \n                    https:\/\/doi.org\/10.1016\/j.scr.2018.04.003","journal-title":"Stem Cell Res"},{"issue":"7337","key":"2151_CR52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature09747","volume":"471","author":"I Itzhaki","year":"2011","unstructured":"Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, Feldman O, Gepstein A, Arbel G, Hammerman H, Boulos M, Gepstein L (2011) Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471(7337):225\u2013229. \n                    https:\/\/doi.org\/10.1038\/nature09747","journal-title":"Nature"},{"issue":"8","key":"2151_CR53","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/eurheartj\/ehr073","volume":"32","author":"E Matsa","year":"2011","unstructured":"Matsa E, Rajamohan D, Dick E, Young L, Mellor I, Staniforth A, Denning C (2011) Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. Eur Heart J 32(8):952\u2013962. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehr073","journal-title":"Eur Heart J"},{"issue":"24","key":"2151_CR54","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1038\/emboj.2013.240","volume":"32","author":"M Bellin","year":"2013","unstructured":"Bellin M, Casini S, Davis RP, D'Aniello C, Haas J, Ward-van Oostwaard D, Tertoolen LG, Jung CB, Elliott DA, Welling A, Laugwitz KL, Moretti A, Mummery CL (2013) Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome. EMBO J 32(24):3161\u20133175. \n                    https:\/\/doi.org\/10.1038\/emboj.2013.240","journal-title":"EMBO J"},{"issue":"2","key":"2151_CR55","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1242\/dmm.008409","volume":"5","author":"AL Lahti","year":"2012","unstructured":"Lahti AL, Kujala VJ, Chapman H, Koivisto AP, Pekkanen-Mattila M, Kerkela E, Hyttinen J, Kontula K, Swan H, Conklin BR, Yamanaka S, Silvennoinen O, Aalto-Setala K (2012) Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis Model Mech 5(2):220\u2013230. \n                    https:\/\/doi.org\/10.1242\/dmm.008409","journal-title":"Dis Model Mech"},{"issue":"1","key":"2151_CR56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jacc.2018.04.041","volume":"72","author":"P Garg","year":"2018","unstructured":"Garg P, Oikonomopoulos A, Chen H, Li Y, Lam CK, Sallam K, Perez M, Lux RL, Sanguinetti MC, Wu JC (2018) Genome editing of induced pluripotent stem cells to decipher cardiac channelopathy variant. J Am Coll Cardiol 72(1):62\u201375. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2018.04.041","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2151_CR57","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/CIRCRESAHA.111.243139","volume":"109","author":"D Malan","year":"2011","unstructured":"Malan D, Friedrichs S, Fleischmann BK, Sasse P (2011) Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro. Circ Res 109(8):841\u2013847. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.243139","journal-title":"Circ Res"},{"key":"2151_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/JAHA.116.005135","volume":"6","author":"CC Veerman","year":"2017","unstructured":"Veerman CC, Mengarelli I, Lodder EM, Kosmidis G, Bellin M, Zhang M, Dittmann S, Guan K, Wilde AAM, Schulze-Bahr E, Greber B, Bezzina CR, Verkerk AO (2017) Switch from fetal to adult SCN5A isoform in human induced pluripotent stem cell-derived cardiomyocytes unmasks the cellular phenotype of a conduction disease-causing mutation. J Am Heart Assoc 6:7. \n                    https:\/\/doi.org\/10.1161\/JAHA.116.005135","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"2151_CR59","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F (2013) Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8(11):2281\u20132308. \n                    https:\/\/doi.org\/10.1038\/nprot.2013.143","journal-title":"Nat Protoc"},{"key":"2151_CR60","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3389\/fimmu.2016.00375","volume":"7","author":"MA Shabbir","year":"2016","unstructured":"Shabbir MA, Hao H, Shabbir MZ, Hussain HI, Iqbal Z, Ahmed S, Sattar A, Iqbal M, Li J, Yuan Z (2016) Survival and evolution of CRISPR-Cas system in prokaryotes and its applications. Front Immunol 7:375. \n                    https:\/\/doi.org\/10.3389\/fimmu.2016.00375","journal-title":"Front Immunol"},{"issue":"1","key":"2151_CR61","doi-asserted-by":"publisher","first-page":"e0169931","DOI":"10.1371\/journal.pone.0169931","volume":"12","author":"M Zaboikin","year":"2017","unstructured":"Zaboikin M, Zaboikina T, Freter C, Srinivasakumar N (2017) Non-homologous end joining and homology directed DNA repair frequency of double-stranded breaks introduced by genome editing reagents. PLoS ONE 12(1):e0169931. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0169931","journal-title":"PLoS ONE"},{"issue":"10","key":"2151_CR62","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1161\/CIRCRESAHA.116.310370","volume":"121","author":"AK Johansen","year":"2017","unstructured":"Johansen AK, Molenaar B, Versteeg D, Leitoguinho AR, Demkes C, Spanjaard B, de Ruiter H, Akbari Moqadam F, Kooijman L, Zentilin L, Giacca M, van Rooij E (2017) Postnatal cardiac gene editing using CRISPR\/Cas9 with AAV9-mediated delivery of short guide RNAs results in mosaic gene disruption. Circ Res 121(10):1168\u20131181. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.310370","journal-title":"Circ Res"},{"issue":"1","key":"2151_CR63","doi-asserted-by":"publisher","first-page":"e1408","DOI":"10.1002\/wsbm.1408","volume":"10","author":"WL Chew","year":"2018","unstructured":"Chew WL (2018) Immunity to CRISPR Cas9 and Cas12a therapeutics. Wiley Interdiscip Rev Syst Biol Med 10(1):e1408. \n                    https:\/\/doi.org\/10.1002\/wsbm.1408","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"1","key":"2151_CR64","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.hrthm.2012.09.124","volume":"10","author":"X Lu","year":"2013","unstructured":"Lu X, Yang X, Huang X, Huang C, Sun HH, Jin L, Xu W, Mao H, Guo J, Zhou J, Lian J (2013) RNA interference targeting E637K mutation rescues hERG channel currents and restores its kinetic properties. Heart Rhythm 10(1):128\u2013136. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2012.09.124","journal-title":"Heart Rhythm"},{"issue":"2","key":"2151_CR65","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3892\/etm.2015.2573","volume":"10","author":"G Li","year":"2015","unstructured":"Li G, Ma S, Sun C (2015) RNA interference-based therapeutics for inherited long QT syndrome. Exp Ther Med 10(2):395\u2013400. \n                    https:\/\/doi.org\/10.3892\/etm.2015.2573","journal-title":"Exp Ther Med"},{"issue":"16","key":"2151_CR66","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/eurheartj\/eht067","volume":"35","author":"E Matsa","year":"2014","unstructured":"Matsa E, Dixon JE, Medway C, Georgiou O, Patel MJ, Morgan K, Kemp PJ, Staniforth A, Mellor I, Denning C (2014) Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes. Eur Heart J 35(16):1078\u20131087. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/eht067","journal-title":"Eur Heart J"},{"issue":"9","key":"2151_CR67","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","volume":"67","author":"A Mazzanti","year":"2016","unstructured":"Mazzanti A, Maragna R, Faragli A, Monteforte N, Bloise R, Memmi M, Novelli V, Baiardi P, Bagnardi V, Etheridge SP, Napolitano C, Priori SG (2016) Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3. J Am Coll Cardiol 67(9):1053\u20131058. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2015.12.033","journal-title":"J Am Coll Cardiol"},{"key":"2151_CR68","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1535370213514000","volume":"239","author":"G Li","year":"2014","unstructured":"Li G, Cheng G, Wu J, Ma S, Sun C (2014) New iPSC for old long QT syndrome modeling: putting the evidence into perspective. Exp Biol Med (Maywood) 239:131\u2013140. \n                    https:\/\/doi.org\/10.1177\/1535370213514000","journal-title":"Exp Biol Med (Maywood)"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-019-02151-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-019-02151-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-019-02151-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T23:35:59Z","timestamp":1597966559000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-019-02151-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["2151"],"URL":"https:\/\/doi.org\/10.1007\/s00246-019-02151-x","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"11 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}